Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment Inês Falcão-PiresAdelino F. Leite-Moreira OriginalPaper 28 May 2011 Pages: 325 - 344
The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure Melody ZayaAnita PhanErnst R. Schwarz OriginalPaper 05 June 2011 Pages: 345 - 353
The cardiorenal syndrome in heart failure: cardiac? renal? syndrome? Filippos TriposkiadisRandall C. StarlingJaved Butler OriginalPaper 16 November 2011 Pages: 355 - 366
Determinants of heart failure self-care: a systematic literature review R. Oosterom-CaloA. J. van BallegooijenJ. Brug OriginalPaper 02 December 2011 Pages: 367 - 385
Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes: identifying patients who do not respond to standard therapy Sean P. CollinsChristopher J. LindsellMihai Gheorghiade OriginalPaper 13 December 2011 Pages: 387 - 394
Role of various proteases in cardiac remodeling and progression of heart failure Alison L. MüllerNaranjan S. Dhalla OriginalPaper 08 July 2011 Pages: 395 - 409
Animal models of cardiorenal syndrome: a review Mariusz K. SzymanskiRudolf A. de BoerHans L. Hillege OriginalPaper Open access 10 September 2011 Pages: 411 - 420
Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning? T. A. RehnM. MunkvikO. M. Sejersted OriginalPaper 14 October 2011 Pages: 421 - 436
Resveratrol in cardiovascular disease: what is known from current research? Hong WangYue-Jin YangJian-Jun Li OriginalPaper 19 June 2011 Pages: 437 - 448
Angiogenic therapy for cardiac repair based on protein delivery systems F. R. FormigaE. TamayoM. J. Blanco-Prieto OriginalPaper 07 October 2011 Pages: 449 - 473
Erythropoietin: a future therapy for failing hearts? Lindsey TillingBrian Clapp OriginalPaper 04 November 2011 Pages: 475 - 483
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial Mihai GheorghiadePeter S. PangFaiez Zannad OriginalPaper 20 September 2011 Pages: 485 - 509